What Is R3?
A triple GIP / GLP-1 / glucagon receptor agonist studied for multi-incretin metabolic signaling.
01Definition
R3 is a metabolic research compound. A triple GIP / GLP-1 / glucagon receptor agonist studied for multi-incretin metabolic signaling. It is also known as LY3437943.
Sequence · Synthetic triple-agonist peptide
02Research Mechanism
R3 is a synthetic triple agonist targeting the GIP, GLP-1, and glucagon receptors simultaneously. Research models investigate the combined contribution of all three pathways to glucose regulation, lipid metabolism, and energy expenditure.
Research framing only · No human-use claims
03Key Facts
| Classification | Metabolic |
| Molecular weight | 4,731.32 g/mol |
| Also known as | LY3437943 |
| Purity spec | ≥99% HPLC |
| Verification | MZ Biolabs · 5-panel |
| Use | Research Use Only |
04FAQ
What is R3?
R3 is a metabolic research compound. A triple GIP / GLP-1 / glucagon receptor agonist studied for multi-incretin metabolic signaling. It is also known as LY3437943. It is supplied strictly for laboratory research use.
What class of compound is R3?
R3 is categorized as Metabolic and is studied alongside related compounds in that research area.
What is the molecular weight of R3?
R3 has a molecular weight of 4,731.32 g/mol.
How is R3 tested?
Every Ethos Bio lot of R3 is analyzed by an independent third-party laboratory (MZ Biolabs, Arizona) on a five-point panel — HPLC purity, mass-spec identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis.